#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Treatment of Asthma and COPD

We recommend the GOLD strategy

Current Approaches to COPD Therapy According to GOLD Recommendations and in the Conditions of Czech Practice

15. 11. 2022 Source: Treatment of Asthma and COPD

Chronic Obstructive Pulmonary Disease (COPD) represents a significant global cause of morbidity and mortality with a high prevalence that is expected to increase significantly in the coming years. Since it is a preventable and treatable disease, active therapy, which is globally guided by international recommendations based on the GOLD strategy, plays an important role. However, in the following article, we will also place these recommendations in the current context of care for these patients in the Czech Republic.

plicní rehabilitace

Impact of Rehabilitation on the Health of Patients with COPD

According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), pulmonary…
15. 11. 2022 Source: Treatment of Asthma and COPD
chronické obstrukční plicní nemoci_dýchání

Current Findings on Fixed Combination Aclidinium/Formoterol in COPD Therapy

The fixed inhalation combination of aclidinium/formoterol represents a combination of a long-acting…
30. 8. 2022 Source: Treatment of Asthma and COPD

Articles on this topic
CHOPN_lékař_pacient

Overview of the Efficacy of the Fixed Combination Aclidinium-Bromide/Formoterol-Fumarate in the Maintenance Treatment of COPD

Fixed combination inhalation medications have become the cornerstone of pharmacotherapy for…
30. 8. 2022 Source: Treatment of Asthma and COPD
CHOPN_pacient

How to Detect COPD Early in Primary Care?

Chronic obstructive pulmonary disease (COPD) can be present even in individuals without…
6. 4. 2022 Source: Treatment of Asthma and COPD
Guidelines_kompas

News in COPD Treatment Recommendations in a Nutshell

We present an overview of the most important changes in the annually updated recommendations…
6. 4. 2022 Source: Treatment of Asthma and COPD
PL_preklad_studium_studie_vyzkum_data_zprava

Efficacy and Safety of Dual Bronchodilator Therapy for COPD – From Randomized Clinical Trials to Real-World Clinical Practice

Dual bronchodilator therapy (LAMA + LABA) represents one of the mainstays of treating chronic…
18. 11. 2021 Source: Treatment of Asthma and COPD
astma plíce chopn grafika novinka

Do Asthma Bronchiale and COPD Represent a Risk Factor for Severe COVID-19 and Death?

It is well known that patients with bronchial asthma and chronic obstructive pulmonary disease…
8. 11. 2021 Source: Treatment of Asthma and COPD
Plíce_snímek_tablet_lékaři

Position of the Aclidinium-Bromide/Formoterol-Fumarate Combination in COPD Treatment According to Current Recommendations

Dual bronchodilator therapy, which combines long-acting muscarinic antagonists (LAMA) and…
3. 6. 2021 Source: Treatment of Asthma and COPD
PL_doktor_studie_starsi

Profile of the effect of aclidinium bromide compared to glycopyrronium bromide

A study by Spanish authors examined the profiles of 2 long-acting muscarinic receptor…
29. 3. 2021 Source: Treatment of Asthma and COPD
PL_zena_mlada_inhalator_chopn_astma

Genuair®/Pressair® Inhaler in the Treatment of COPD – Minimum Errors During Inhalation and High Patient Satisfaction

The article by German authors summarizes the results achieved with the Genuair® inhaler…
29. 3. 2021 Source: Treatment of Asthma and COPD
pacient lékař konzultace prohlídka

Focus on the Connections Between Gastroesophageal Reflux Disease and COPD Exacerbations

In recent years, evidence has emerged of a higher prevalence of gastroesophageal reflux…
1. 9. 2020 Source: Treatment of Asthma and COPD
PL_mobil_digitalni_technologie

Digital Technology in COPD Therapy: Current Options and Future Prospects

This year, digital technologies have demonstrated their advantages in interpersonal…
1. 9. 2020 Source: Treatment of Asthma and COPD

1 2
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#